Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher - Foghorn Therapeutics (NASDAQ:FHTX)

Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.

Related Keywords

Vikram Purohit ,Morgan Stanley ,Foghorn Therapeutics Inc ,Eli Lilly And ,Gene Traffic Control ,Foghorn Therapeutics ,Wall Street ,Benzinga Pro ,